Literature DB >> 27685898

Ganoderma Lucidum (Reishi Mushroom) and cancer.

Ahmet Unlu1, Erdinc Nayir, Onder Kirca, Mustafa Ozdogan.   

Abstract

Having a long historical past in traditional Chinese medicine, Ganoderma Lucidum (G. Lucidum) is a type of mushroom believed to extend life and promote health. Due to the increasing consumption pattern, it has been cultivated and marketed intensively since the 1970s. It is claimed to be effective in the prevention and treatment of many diseases, and in addition, it exerts anticancer properties. Almost all the data on the benefits of G. Lucidum are based on laboratory and preclinical studies. The few clinical studies conducted are questionable. Nevertheless, when the findings obtained from laboratory studies are considered, it turns that G. Lucidum is likely to have some benefits for cancer patients. What is important at this point is to determine the components that will provide these benefits, and use them in drug development, after testing their reliability. In conclusion, it would be the right approach to abstain from using and incentivizing this product, until its benefits and harms are set out clearly, by considering its potential side effects.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27685898

Source DB:  PubMed          Journal:  J BUON        ISSN: 1107-0625            Impact factor:   2.533


  5 in total

1.  Regulation of Nrf2 and Nrf2-related proteins by ganoderma lucidum ın hepatocellular carcinoma.

Authors:  Ramin Aslaminabad; Negin Rahimianshahreza; Seyed Amirhossein Hosseini; Güliz Armagan; Ahmad Kashif Khan; Gülüzar Özbolat; Omar Saad Ahmed; Amir Mardi Azar; Ali Adili; Taner Dağcı; Sibel Konyalıoğlu; Ali Mert Özgönül
Journal:  Mol Biol Rep       Date:  2022-08-29       Impact factor: 2.742

Review 2.  Chinese Medicines in the Treatment of Prostate Cancer: From Formulas to Extracts and Compounds.

Authors:  Xueni Wang; Gang Fang; Yuzhou Pang
Journal:  Nutrients       Date:  2018-02-28       Impact factor: 5.717

Review 3.  Ganoderma: A Cancer Immunotherapy Review.

Authors:  Yu Cao; Xiaowei Xu; Shujing Liu; Linfang Huang; Jian Gu
Journal:  Front Pharmacol       Date:  2018-10-25       Impact factor: 5.810

4.  GSNOR regulates ganoderic acid content in Ganoderma lucidum under heat stress through S-nitrosylation of catalase.

Authors:  Rui Liu; Ting Zhu; Xin Chen; Zi Wang; Zhengyan Yang; Ang Ren; Liang Shi; Hanshou Yu; Mingwen Zhao
Journal:  Commun Biol       Date:  2022-01-11

5.  Ganoderma lucidum Rhodiola compound preparation prevent D-galactose-induced immune impairment and oxidative stress in aging rat model.

Authors:  Shuo Yuan; Yong Yang; Jiao Li; Xiaoyu Tan; Yuying Cao; Shaoheng Li; Hee-Do Hong; Liping Liu; Qinggao Zhang
Journal:  Sci Rep       Date:  2020-11-06       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.